By Deanna Neff HealthDay ReporterTHURSDAY, Feb. 19, 2026 (HealthDay News) — In a sudden reversal, the U.S. Food and Drug Administration (FDA) has agreed to review Moderna’s experimental mRNA influenza ...

Think your credit score is safe? Experts warn everyday habits like BNPL and cash withdrawals could trigger rejections. Check these red flags now.

Moderna announced that the FDA will review its new mRNA flu vaccine, a reversal less than two weeks after the agency refused to do so.

The FDA outright refuses to review Moderna’s mRNA-based flu vaccine as CBER director Vinay Prasad’s conduct is scrutinized; Disc Medicine receives an unexpected rejection, which Prasad may also have ...

Perfectionism is often seen as a virtue, but there’s a difference between healthy striving and maladaptive perfectionism—a pattern driven by fear of failure, external validation, and a sense of ...

Siddhant Chaturvedi is all set to captivate audiences with yet another strong performance in Do Deewane Seher Mein. The actor ...

The Food and Drug Administration rejected Moderna's new flu shot. This raises questions about what it means for the future of vaccine development.

Opinion Columnist Kira Walter '26 defends the commonly frowned upon notion of "simping" and argues that embracing emotional ...

Munich Security Conference organizers should withdraw the invitation to Pahlavi and invite genuine representatives of Iran’s ...

The move signals an escalation in the agency’s efforts to interfere with established procedures for testing and approving ...

Moderna’s mRNA-1010 was expected to contribute $1 billion to the company’s coffers by 2028. That plan is now out the window after the FDA refused to even look at the application.

Real estate experts say the American Dream is evolving as buyers ditch mahogany "McMansions" for energy-efficient homes with pickleball courts and smart tech.